Discovering naturally processed antigenic determinants that confer protective T cell immunity.

CD8+ T cells (TCD8) confer protective immunity against many infectious diseases, suggesting that microbial TCD8 determinants are promising vaccine targets. Nevertheless, current T cell antigen identification approaches do not discern which epitopes drive protective immunity during active infection - information that is critical for the rational design of TCD8-targeted vaccines. We employed a proteomics-based approach for large-scale discovery of naturally processed determinants derived from a complex pathogen, vaccinia virus (VACV), that are presented by the most frequent representatives of four major HLA class I supertypes. Immunologic characterization revealed that many previously unidentified VACV determinants were recognized by smallpox-vaccinated human peripheral blood cells in a variegated manner. Many such determinants were recognized by HLA class I-transgenic mouse immune TCD8 too and elicited protective TCD8 immunity against lethal intranasal VACV infection. Notably, efficient processing and stable presentation of immune determinants as well as the availability of naive TCD8 precursors were sufficient to drive a multifunctional, protective TCD8 response. Our approach uses fundamental insights into T cell epitope processing and presentation to define targets of protective TCD8 immunity within human pathogens that have complex proteomes, suggesting that this approach has general applicability in vaccine sciences.

[1]  J. Harty,et al.  Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites , 2010, PLoS pathogens.

[2]  A. Rothman,et al.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. , 2008, Human immunology.

[3]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[4]  S. Jameson,et al.  IL-2 Complex Treatment Can Protect Naive Mice from Bacterial and Viral Infection , 2010, The Journal of Immunology.

[5]  J. Sidney,et al.  Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes. , 2003, Human immunology.

[6]  Rovshan G Sadygov,et al.  Code developments to improve the efficiency of automated MS/MS spectra interpretation. , 2002, Journal of proteome research.

[7]  Bali Pulendran,et al.  Immunological mechanisms of vaccination , 2011, Nature Immunology.

[8]  J. LaBaer,et al.  Proteomics: A Cold Spring Harbor Laboratory Course Manual , 2008 .

[9]  M. Washburn,et al.  Analysis of Protein Composition Using Multidimensional Chromatography and Mass Spectrometry , 2003, Current protocols in protein science.

[10]  C Oseroff,et al.  Human memory CTL response specific for influenza A virus is broad and multispecific. , 2000, Human immunology.

[11]  A. Kelso,et al.  Prospects for an influenza vaccine that induces cross‐protective cytotoxic T lymphocytes , 2009, Immunology and cell biology.

[12]  H. Rammensee,et al.  Long-Term Immunity against Actual Poxviral HLA Ligands as Identified by Differential Stable Isotope Labeling1 , 2008, The Journal of Immunology.

[13]  M. Slifka,et al.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans. , 2011, Virology.

[14]  Marion Pepper,et al.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.

[15]  J. Yates,et al.  Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.

[16]  Alessandro Sette,et al.  Reverse vaccinology: developing vaccines in the era of genomics. , 2010, Immunity.

[17]  G. Altan-Bonnet,et al.  Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses , 2012, Proceedings of the National Academy of Sciences.

[18]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[19]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[20]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[21]  M. Plebanski,et al.  Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi‐immune adults in The Gambia , 2004, Clinical and experimental immunology.

[22]  Thomas Quast,et al.  Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs , 2010, Nature Immunology.

[23]  A. Sette,et al.  Memory CD8+ T Cells Specific for a Single Immunodominant or Subdominant Determinant Induced by Peptide-Dendritic Cell Immunization Protect from an Acute Lethal Viral Disease , 2012, Journal of Virology.

[24]  S. Behar,et al.  Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo1 , 2008, The Journal of Immunology.

[25]  Philip J. R. Goulder,et al.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.

[26]  S. Jameson,et al.  Derivation and Maintenance of Virtual Memory CD8 T Cells , 2012, The Journal of Immunology.

[27]  Y. Suezer,et al.  Critical Role of Perforin-dependent CD8+ T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox , 2012, PLoS pathogens.

[28]  Yang Wang,et al.  Altered CD8+ T Cell Immunodominance after Vaccinia Virus Infection and the Naive Repertoire in Inbred and F1 Mice , 2009, The Journal of Immunology.

[29]  Andrew J Link,et al.  Analyzing Proteomes and Protein Function Using Graphical Comparative Analysis of Tandem Mass Spectrometry Results* , 2006, Molecular & Cellular Proteomics.

[30]  J. Kohlmeier,et al.  Immunity to respiratory viruses. , 2009, Annual review of immunology.

[31]  M. Bevan.  Understand memory, design better vaccines , 2011, Nature Immunology.

[32]  H Robert Bergen,et al.  Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development. , 2009, Vaccine.

[33]  Magdalini Moutaftsi,et al.  Correlates of protection efficacy induced by vaccinia virus‐specific CD8+ T‐cell epitopes in the murine intranasal challenge model , 2009, European journal of immunology.

[34]  E. Celis,et al.  Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. , 2009, Cancer research.

[35]  I. M. Belyakov,et al.  Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8+ T-Cell Peptide Epitope of Vaccinia and Variola Viruses , 2004, Journal of Virology.

[36]  P. Andersen,et al.  Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells1 , 2009, The Journal of Immunology.

[37]  P. Doherty,et al.  Cell-mediated Protection in Influenza Infection , 2006, Emerging infectious diseases.

[38]  Bjoern Peters,et al.  HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. , 2005, The Journal of Immunology.

[39]  S. Riddell,et al.  Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. , 1994, Blood.

[40]  F. Lemonnier,et al.  Multiple Viral Ligands Naturally Presented by Different Class I Molecules in Transporter Antigen Processing-Deficient Vaccinia Virus-Infected Cells , 2011, Journal of Virology.

[41]  D. Tscharke,et al.  Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines , 2005, The Journal of experimental medicine.

[42]  F. Zepp.  Principles of vaccine design-Lessons from nature. , 2010, Vaccine.

[43]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[44]  S. Jameson,et al.  The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion , 2009, The Journal of experimental medicine.

[45]  M. Croft,et al.  CD8 T Cells Are Essential for Recovery from a Respiratory Vaccinia Virus Infection , 2012, The Journal of Immunology.

[46]  D. Karzon,et al.  PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY. , 1964, Annals of internal medicine.

[47]  J. Altman,et al.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.

[48]  Annette S. Kim,et al.  Viral acute lower respiratory infections impair CD8+ T cells through PD-1. , 2012, The Journal of clinical investigation.

[49]  R. Steinman,et al.  Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .

[50]  S. Behar,et al.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. , 2006, Critical reviews in immunology.

[51]  Analysis of A47, an Immunoprevalent Protein of Vaccinia Virus, Leads to a Reevaluation of the Total Antiviral CD8+ T Cell Response , 2010, Journal of Virology.

[52]  W. Ripley Ballou,et al.  Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1 , 2003, The Journal of Immunology.

[53]  D. Montefiori,et al.  Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses1 , 2002, The Journal of Immunology.

[54]  J. Hooper,et al.  The strategic use of novel smallpox vaccines in the post-eradication world , 2011, Expert review of vaccines.

[55]  Sang-Ho Kim,et al.  Principles of , 2013 .

[56]  G. Giaccone,et al.  A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  M. Slifka,et al.  Wanted, dead or alive: new viral vaccines. , 2009, Antiviral research.

[58]  M. Jenkins,et al.  The Role of Naive T Cell Precursor Frequency and Recruitment in Dictating Immune Response Magnitude , 2012, The Journal of Immunology.

[59]  J. Yewdell,et al.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. , 2006, Immunity.

[60]  E. R. James,et al.  Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity , 2011, Science.

[61]  Mark Lindsey,et al.  Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501 , 1997, Immunogenetics.

[62]  K. Reimann,et al.  Smallpox vaccine safety is dependent on T cells and not B cells. , 2011, The Journal of infectious diseases.

[63]  R. Angeletti,et al.  A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides , 1994, The Journal of experimental medicine.

[64]  V. Cerundolo,et al.  Harnessing invariant NKT cells in vaccination strategies , 2009, Nature Reviews Immunology.

[65]  Bjoern Peters,et al.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Ton N Schumacher,et al.  Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers , 2009, Nature Methods.

[67]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[68]  Morten Nielsen,et al.  Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity , 2012, European journal of immunology.

[69]  T. Elliott,et al.  Proteasomes, TAP, and Endoplasmic Reticulum-Associated Aminopeptidase Associated with Antigen Processing Control CD4+ Th Cell Responses by Regulating Indirect Presentation of MHC Class II-Restricted Cytoplasmic Antigens , 2011, The Journal of Immunology.